Purpose
to assess the feasibility of mRNA technology to deliver antibody combinations in selected neonates in low resource settings in order to reduce the impact of neonatal sepsis in this vulnerable population
Grantee
Division
Global Health
Date
MARCH 2019
Region served
GLOBAL
Committed amount
$1,051,128
Grant topic
Discovery and Translational Sciences
Duration (months)
9
Grantee location
Cambridge, Massachusetts, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.